Alpha Wave Global
LIMNW icon

Alpha Wave Global’s Liminatus Pharma Warrants LIMNW Stock Holding History

Alpha Wave Global’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-89,098
Closed -$10.7K – 32
2025
Q3 		$10.7K Hold
89,098
– – ﹤0.01% 26
2025
Q2 		$21.6K Buy
+89,098
New +$17.5K ﹤0.01% 31

Other funds holding LIMNW

Clear Street
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Aristeia Capital
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
Linden Advisors
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Saba Capital Management
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Moore Capital Management
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

Alpha Wave Global's LIMNW Position: Q4 2025 in Review

Alpha Wave Global sold out of Liminatus Pharma Warrants (LIMNW) in Q4 2025, closing a stake of 89,098 shares — an estimated $10.7K sold.

Alpha Wave Global first reported a position in LIMNW in Q2 2025 and held it in 2 quarters. The position peaked at $21.6K in Q2 2025. 24 funds tracked by Wall St. Rank hold LIMNW as of Q4 2025.

  • Alpha Wave Global reported no remaining Liminatus Pharma Warrants position as of Q4 2025 after selling out during the quarter.
  • Alpha Wave Global sold 89,098 Liminatus Pharma Warrants shares in Q4 2025, an estimated $10.7K.
  • Alpha Wave Global first reported a position in Liminatus Pharma Warrants in Q2 2025 and held it in 2 quarters.
  • Alpha Wave Global's Liminatus Pharma Warrants position peaked at $21.6K in Q2 2025.
  • 24 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q4 2025.

Based on Alpha Wave Global's 13F filing for Q4 2025, filed 13 Feb 2026.